Method for determining content of clindamycin phosphate vaginal tablets
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- HAINAN HAISHEN TONGZHOU PHARM CO LTD
- Publication Date
- 2021-04-20
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the field of drug analysis, in particular to a method for determining the content of clindamycin phosphate vaginal tablets. Background technique
[0002] Clindamycin phosphate is a semi-synthetic antibacterial drug widely used in serious infections caused by Gram-positive cocci and anaerobic bacteria. It is a semi-synthetic antibiotic and a derivative of lincomycin. Clindamycin phosphate is ineffective in vitro and can be rapidly converted into antibacterially effective clindamycin in vivo. The clindamycin phosphate vaginal tablet has a high cure rate and a short course of treatment for bacterial vaginosis, and has the characteristics of convenient production and use and quick onset of effect.
[0003] Patent CN103487518B, using octadecylsilane bonded silica gel as filler; potassium dihydrogen phosphate solution-methanol as mobile phase, using high performance liquid chromatography for detection, the key control detection cond...